CSL Behring

CSL Behring is a global leader in the plasma protein bio therapeutics industry.

The CSL Group produces life-saving and life-enhancing medicines that enable people with rare and serious diseases from around the world to lead normal healthy lives.

Users of our therapies rely on them for their quality of life and, in many cases, for life itself.

As a trusted and respected provider of healthcare solutions to many communities globally, CSL is committed to the development, manufacture and supply of high quality, safe products that improve the health and well-being of our patients..

We aim to identify, develop and commercialize important, new, bio therapeutic products that help to save lives by preventing or treating serious medical conditions.

These conditions include:
- Haemophilia, von Willebrand disease and Other Coagulation Disorders
- Conditions requiring immunoglobulin therapy, such as primary immunodeficiency and secondary immunodeficiency
- Specialty Care Products to treat hereditary angioedema, acquired bleeding, shock, sepsis and severe burns,

With major facilities in Australia, Germany, Switzerland and the US, CSL has over 13,000 employees working in 30 countries.

CSL Behring
Bedrijvenlaan 11
B-2800 Mechelen
Tel: +32 15 28 89 20

[email protected]

You link to Hemophilia

Click here for more information on MEDIPEDIA

© Copyright 2021 - Belgian Society on Thrombosis and Haemostasis - All rights reserved.